Agmatine: Metabolic pathway and spectrum of activity in brain

CNS Drugs

Volumn 21, Issue 11, 2007, Pages 885-900

  Halaris, Angelos ^a,b   Plietz, John ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Agmatine, general; Anxiety; Depression; Post traumatic stress disorder

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BRIMONIDINE; IDAZOXAN; IMIDAZOLINE I1 RECEPTOR; IMIPRAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; YOHIMBINE;

ACUTE STRESS DISORDER; ALCOHOLISM; ANTICONVULSANT ACTIVITY; ANXIETY DISORDER; ASTROCYTE; BEHAVIOR CHANGE; COLD STRESS; DEPOLARIZATION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEAR; HUMAN; HYPOXIA; INFLAMMATION; INJECTION; ISCHEMIA; LOW DRUG DOSE; MAJOR DEPRESSION; MAZE TEST; MENTAL STRESS; METABOLISM; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SPECTROSCOPY; ULCEROGENESIS;

AGMATINE; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; MENTAL DISORDERS; PAIN; SYNAPTIC TRANSMISSION; UREOHYDROLASES;

EID: 35048891421     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200721110-00002     Document Type: Review

References (99)

1. Li G, Regunathan S, Barrow CJ, et al. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994; 263: 966-9
2. Satriano J. Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids 2004; 26: 321-9
3. Zhu M, Iyo A, Piletz J, et al. Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine. Biochim Biophys Acta 2004; 1670: 156-64
4. Reis DJ, Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 2000; 21: 187-93
5. Coleman CS, Hu G, Pegg AE. Putrescine biosynthesis in mammalian tissues. Biochem J 2004; 379: 849-55
6. Iyo AH, Zhu MY, Ordway GA, et al. Expression of arginine decarboxylase in brain regions and neuronal cells. J Neurochem 2006; 96: 1042-50
7. Goracke-Postle CJ, Nguyen HO, Stone LS, et al. Release of tritiated agmatine from spinal synaptosomes. Neuroreport 2006; 17: 13-7
8. Reis DJ, Yang XC, Milner TA. Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci Lett 1998; 250: 185-8
9. Su R, Wei X, Zheng J, et al. Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav 2004; 77: 345-9
10. Riazi K, Honar H, Homayoun H, et al. The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors. Epilepsy Res 2005; 65: 33-40
11. Zhu MY, Wang WP, Bissette G. Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience 2006; 141 (4): 2019-27
12. Gilad GM, Gilad VH, Finberg JP, et al. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Neurochem Res 2005; 30: 713-9
13. Wang WP, Iyo AH, Miguel-Hidalgo J, et al. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res 2006; 1084: 210-6
14. Halaris A, Piletz J. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci 2003; 1009: 1-20
15. Aricioglu F, Regunathan S. Agmatine attenuates stress- and lipopolysaccharide-induced fever in rats. Physiol Behav 2005; 85: 370-5
16. Reis DJ, Piletz JE. The imidazoline receptor in control of blood pressure by clonidine and allied drugs. Am J Physiol 1997; 273: R1569-71
17. Eglen RM, Hudson AL, Kendall DA, et al. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol Sci 1998; 19: 381-90
18. Raasch W, Schafer U, Qadri F, et al. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol 2002; 135: 663-72
19. Reis DJ, Li G, Regunathan S. Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine. Ann N Y Acad Sci 1995; 763: 295-313
20. Aricioglu F, Regunathan S, Piletz J. Is agmatine an endogenous factor against stress? Ann N Y Acad Sci 2003; 1009: 127-32
21. Wu N, Su R, Xu B, et al. IRAS, a candidate for I(1)-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence. Biochem Pharmacol 2005; 70 (7): 1079-87
22. Wu N, Su RB, Liu Y, et al. Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor. Eur J Pharmacol 2006; 548 (1-3): 21-8
23. Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, et al. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 1999; 127: 1317-26
24. Yang XC, Reis DJ. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 1999; 288: 544-9
25. Galea E, Regunathan S, Eliopoulos V, et al. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996; 316: 247-9
26. Demady DR, Jianmongkol S, Vuletich JL, et al. Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol 2001; 59: 24-9
27. Regunathan S, Piletz J. Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci 2003 Dec; 1009: 20-9
28. Piletz J, May P, Wang G, et al. Agmatine crosses the blood-brain barrier. Ann N Y Acad Sci 2003; 1009: 64-74
29. Zomkowski AD, Hammes L, Lin J, et al. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 2002; 13: 387-91
30. Aricioglu F, Altunbas H. Is agmatine an endogenous anxiolytic/ antidepressant agent? Ann N Y Acad Sci 2003; 1009: 136-40
31. Li Y, Gong Z, Cao J, et al. Antidepressant-like effect of agmatine and its possible mechanism. Eur J Pharmacol 2003; 469: 81-8
32. Lavinsky D, Arteni N, Netto C. Agmatine induces anxiolysis in the elevated plus maze task in adult rats. Behav Brain Res 2003; 141: 19-24
33. Stewart LS, McKay BE. Acquisition deficit and time-dependent retrograde amnesia for contextual fear conditioning in agmatine-treated rats. Behav Pharmacol 2000; 11: 93-7
34. Uzbay IT, Yesilyurt O, Celik T, et al. Effects of agmatine on ethanol withdrawal syndrome in rats. Behav Brain Res 2000; 107: 153-9
35. Aricioglu F, Means A, Regunathan S. Effect of agmatine on the development of morphine dependence in rats: potential role of cAMP system. Eur J Pharmacol 2004; 504: 191-7
36. Wei X, Su R, Lu X, et al. Inhibition by agmatine on morphine-induced conditioned place preference in rats. Eur J Pharmacol 2005; 515: 99-106
37. Fullerton CS, Ursano RJ, Wang L. Acute stress disorder, posttraumatic stress disorder, and depression in disaster or rescue workers. Am J Psychiatry 2004; 161: 1370-6
38. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem 1984; 53: 749-90
39. Molderings G, Bruss M, Bonisch H, et al. Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines. Ann N Y Acad Sci 2003; 1009: 75-81
40. Mistry SK, Burwell TJ, Chambers RM, et al. Cloning of human agmatinase: an alternate path for polyamine synthesis induced in liver by hepatitis B virus. Am J Physiol Gastrointest Liver Physiol 2002; 282: G375-81
41. Iyer R, Kim H, Tsoa R, et al. Cloning and characterization of human agmatinase. Mol Genet Metab 2002; 75: 209-18
42. Morris S. Recent advances in arginine metabolism. Curr Opin Clin Nutr Metab Care 2004; 7: 45-51
43. Gorbatyuk OS, Milner TA, Wang G, et al. Localization of agmatine in vasopressin and oxytocin neurons of the rat hypothalamic paraventricular and supraoptic nuclei. Exp Neurol 2001; 171: 235-45
44. Piletz JE, Chikkala DN, Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther 1995; 272: 581-7
45. Zheng J, Weng X, Gai X, et al. Mechanism underlying blockade of voltage-gated calcium channels by agmatine in cultured rat hippocampal neurons. Acta Pharmacol Sin 2004; 25: 281-5
46. Askalany A, Yamakura T, Petrenko A, et al. Effect of agmatine on heteromeric N-methyl-d-aspartate receptor channels. Neurosci Res 2005; 52: 387-92
47. Loring RH. Agmatine acts as an antagonist of neuronal nicotinic receptors. Br J Pharmacol 1990; 99: 207-11
48. Molderings GJ, Schmidt K, Bonisch H, et al. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 245-52
49. Otake K, Ruggiero DA, Regunathan S, et al. Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res 1998; 787: 1-14
50. Sastre M, Regunathan S, Reis DJ. Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J Neurochem 1997; 69: 2421-6
51. Molderings G, Heinen A, Menzel S, et al. Gastrointestinal uptake of agmatine: distribution in tissues and organs and pathophysiologic relevance. Ann N Y Acad Sci 2003; 1009: 44-51
52. Sastre M, Regunathan S, Galea E, et al. Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J Neurochem 1996; 67: 1761-5
53. Auguet M, Viossat I, Marin JG, et al. Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 1995; 69: 285-7
54. Feng Y, LeBlanc MH, Regunathan S. Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci Lett 2005; 390: 129-33
55. Abe K, Abe Y, Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res 2000; 872: 141-8
56. Abe K, Abe Y, Saito H. Agmatine induces glutamate release and cell death in cultured rat cerebellar granule neurons. Brain Res 2003; 990: 165-71
57. Satriano J, Schwartz D, Ishizuka S, et al. Suppression of inducible nitric oxide generation by agmatine aldehyde: beneficial effects in sepsis. J Cell Physiol 2001; 188: 313-20
58. Khoshnoodi MA, Motiei-Langroudi R, Tahsili-Fahadan P, et al. Involvement of nitric oxide system in enhancement of morphine-induced conditioned place preference by agmatine in male mice. Neurosci Lett 2006; 399 (3): 234-9
59. Roberts J, Grocholski B, Kitto K, et al. Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. J Pharmacol Exp Ther 2005; 314: 1226-33
60. Feng Y, Halaris AE, Piletz JE. Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection [published erratum appears in J Chromatogr B Biomed Sci Appl 1997 Aug 15; 696 (1): 173]. J Chromatogr B Biomed Sci Appl 1997; 691 (2): 277-82
61. Zhang W, Kaye D. Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled orthophthaldialdehyde precolumn derivatization. Anal Biochem 2004; 326: 87-92
62. Zhao S, Wang B, Yuan H, et al. Determination of agmatine in biological samples by capillary electrophoresis with optical fiber light-emitting-diode- induced fluorescence detector. J Chromatogr A 2006; 1123: 138-41
63. Dias Elpo Zomkowski A, Oscar Rosa A, Lin J, et al. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 2004; 1023: 253-63
64. Zomkowski A, Santos A, Rodrigues A. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci Lett 2005; 381: 279-83
65. Gonzalez C, Regunathan S, Reis DJ, et al. Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br J Pharmacol 1996; 119: 677-84
66. Zhao D, Ren L. Non-adrenergic inhibition at prejunctional sites by agmatine of purinergic vasoconstriction in rabbit saphenous artery. Neuropharmacology 2005; 48: 597-606
67. Wang H, Regunathan S, Youngson C, et al. An antibody to agmatine localizes the amine in bovine adrenal chromaffin cells. Neurosci Lett 1995; 183: 17-21
68. Regunathan S, Youngson C, Raasch W, et al. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J Pharmacol Exp Ther 1996; 276: 1272-82
69. Briaud S, Zhang BL, Sannajust F. Central actions of agmatine in conscious spontaneously hypertensive rats. Clin Exp Hypertens 2005; 27: 619-27
70. Tahsili-Fahadan P, Yahyavi-Firouz-Abadi N, Khoshnoodi MA, et al. Agmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha(2)-adrenoceptors. Neuropsychopharmacology 2006; 31 (8): 1722-32
71. Sener A, Lebrun P, Blachier F, et al. Stimulus-secretion coupling of arginine-induced insulin release: insulinotropic action of agmatine. Biochem Pharmacol 1989; 38: 327-30
72. Kalra SP, Pearson E, Sahu A, et al. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci Lett 1995; 194: 165-8
73. Molderings GJ, Gothert M. Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites. Naunyn Schmiedebergs Arch Pharmacol 1995; 351: 507-16
74. Regunathan S, Feinstein DL, Reis DJ. Anti-proliferative and anti-inflammatory actions of imidazoline agents: are imidazoline receptors involved? Ann N Y Acad Sci 1999; 881: 410-9
75. Gilad VH, Rabey JM, Kimiagar Y, et al. The polyamine stress response: tissue-, endocrine-, and developmental-dependent regulation. Biochem Pharmacol 2001; 61: 207-13
76. Gilad GM, Gilad VH. Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell Mol Neurobiol 2003; 23: 637-49
77. Gilad GM, Gilad VH. Brain polyamine stress response: recurrence after repetitive stressor and inhibition by lithium. J Neurochem 1996; 67: 1992-6
78. Elgun S, Kumbasar H. Increased serum arginase activity in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2000; 24: 227-32
79. Halaris A, Zhu H, Feng Y, et al. Plasma agmatine and platelet imidazoline receptors in depression. Ann N Y Acad Sci 1999; 881: 445-51
80. Sastre M, Galea E, Feinstein D, et al. Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines. Biochem J 1998; 330: 1405-9
81. Gilad GM, Gilad VH, Rabey JM. Arginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemia. Neurosci Lett 1996; 216: 33-6
82. Feng Y, Piletz JE, Leblanc MH. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 2002; 52: 606-11
83. Fairbanks C, Kaminski L, Nguyen H, et al. Pre-treatment with antisera raised against agmatine sensitizes mice to plasticity-mediated events [abstract]. Soc Neurosci Abstr 2001; 27: 465
84. Aricioglu-Kartel F, Reis D, Regunathan S. Agmatine and morphine tolerance/dependance: molecular mechanisms of interactions [abstract]. Soc Neurosci Abstr 2001; 27: 685
85. Gilad GM, Salame K, Rabey JM, et al. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci 1996; 58: 41-6
86. Gilad GM, Gilad VH. Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett 2000; 296: 97-100
87. Fairbanks CA, Schreiber KL, Brewer KL, et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A 2000; 97: 10584-9
88. Onal A, Delen Y, Ulker S, et al. Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum. Life Sci 2003; 73: 413-28
89. Aricioglu F, Korcegez E, Bozkurt A, et al. Effect of agmatine on acute and mononeuropathic pain. Ann N Y Acad Sci 2003; 1009: 106-15
90. Kolesnikov Y, Jain S, Pasternak GW. Modulation of opioid analgesia by agmatine. Eur J Pharmacol 1996; 296: 17-22
91. Li J, Li X, Pei G, et al. Effects of agmatine on tolerance to and substance dependence on morphine in mice. Chung Kuo Yao Li Hsueh Pao 1999; 20: 232-8
92. Aricioglu-Kartal F, Uzbay IT. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci 1997; 61: 1775-81
93. McKay B, Lado W, Martin L, et al. Learning and memory in agmatine-treated rats. Pharmacol Biochem Behav 2002; 72: 551-7
94. McKay B, Persinger M. Combined effects of complex magnetic fields and agmatine for contextual fear learning deficits in rats. Life Sci 2003; 72: 2489-98
95. Porsolt RD, Anton G, Blavet N, et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47: 379-91
96. Porsolt RD, Deniel M, Jalfre M. Forced swimming in rats: hypothermia, immobility and the effects of imipramine. Eur J Pharmacol 1979; 57: 431-6
97. Gilad GM, Gilad VH, Eliyayev Y, et al. Developmental regulation of the brain polyamine-stress-response. Int J Dev Neurosci 1998; 16: 271-8
98. Huang M, Regunathan S, Botta M, et al. Structure-activity analysis of guanidine group in agmatine for brain agmatinase. Ann N Y Acad Sci 2003; 1009: 52-63
99. Piletz J, Huang M, Lee K, inventors. Jackson State University, assignee. Mammalian agmatinase inhibitory substance. US patent application 20050220707; 2004 Apr 5